Fundz

Ascendia Pharmaceuticals

NEW BRUNSWICK, New Jersey, United States · Biotechnology, Healthcare, Manufacturing

Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates.

Key facts

Headquarters
NEW BRUNSWICK, New Jersey, United States
Employees
91
Industries
Biotechnology, Healthcare, Manufacturing
Status
Private
Website
ascendiacdmo.com
LinkedIn
Company page

Recent activity at Ascendia Pharmaceuticals

Ascendia Pharmaceuticals funding history

DateRoundAmount
Jul 2026Venture$4.1M
Jun 2025Seed$2.5M
Oct 2024Venture$2.5M
Jul 2022Venture$2.5M
Apr 2021Venture$5.0M

Leadership

  • Jingjun Huang, Executive Officer, Director
  • Theron Odlaug, Director
  • James Gale, Director
  • Colin Foster, Director
  • Robert Bloder, Director
  • Jingjun Huang, Executive Officer, Director
  • Todd Daviau, Chief Operating Officer
  • Jim Jingjun Huang, Founder
  • Robert Bloder, Chief Business Officer

Verified email and direct lines for Ascendia Pharmaceuticals’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Employee benefit plans

Ascendia Pharmaceuticals files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Ascendia Pharmaceuticals in the news

Companies similar to Ascendia Pharmaceuticals

About Ascendia Pharmaceuticals: questions and answers

What does Ascendia Pharmaceuticals do?

Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates.

Where is Ascendia Pharmaceuticals headquartered?

Ascendia Pharmaceuticals is headquartered in NEW BRUNSWICK, New Jersey, United States.

How many employees does Ascendia Pharmaceuticals have?

Ascendia Pharmaceuticals has about 91 employees.

Has Ascendia Pharmaceuticals raised funding?

Yes. Fundz has recorded 5 funding events for Ascendia Pharmaceuticals. The most recent, $4.1M, was in Jul 2026.

Who leads Ascendia Pharmaceuticals?

Jim Jingjun Huang is a Founder at Ascendia Pharmaceuticals.

What is the latest news on Ascendia Pharmaceuticals?

On Jul 24, 2026, ASCENDIA PHARMACEUTICALS

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Ascendia Pharmaceuticals across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.